China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · IEX Real-Time Price · USD
1.89
-0.06 (-2.83%)
May 26, 2022 3:59 PM EDT - Market closed
Cash Flow Statement (Annual)
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Year | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|
| Net Income | -2.75 | -10.29 | 1.54 | 1.19 | 1.19 |
| Depreciation & Amortization | 0.35 | 0.33 | 0.18 | 0.13 | 0.1 |
| Other Operating Activities | 1.09 | 10.89 | -1.48 | 0.6 | -0.99 |
| Operating Cash Flow | -1.32 | 0.93 | 0.24 | 1.92 | 0.29 |
| Operating Cash Flow Growth | - | 290.58% | -87.54% | 555.25% | - |
| Capital Expenditures | -0.09 | -0.41 | -0.6 | -1.03 | -0.18 |
| Acquisitions | 3.13 | -3.59 | 0 | 0 | 0 |
| Change in Investments | -8.85 | -1.5 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | -0.01 | -0.02 | -0.01 |
| Investing Cash Flow | -5.81 | -5.5 | -0.61 | -1.05 | -0.19 |
| Share Issuance / Repurchase | 0 | 0 | 6.49 | 0 | 0 |
| Debt Issued / Paid | -0.12 | 6.72 | 0.07 | -0.31 | -0.05 |
| Other Financing Activities | 12.53 | -3.7 | 2.48 | 0 | 0 |
| Financing Cash Flow | 12.41 | 3.02 | 9.04 | -0.31 | -0.05 |
| Net Cash Flow | 6.07 | -2 | 8.63 | 0.59 | 0.05 |
| Free Cash Flow | -1.41 | 0.53 | -0.36 | 0.89 | 0.11 |
| Free Cash Flow Growth | - | - | - | 682.03% | - |
| Free Cash Flow Margin | -159.28% | 159.67% | -169.51% | 67.61% | 15.57% |
| Free Cash Flow Per Share | -1.96 | 1.71 | -1.40 | 3.56 | 0.46 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).